Atracurium Besylate (Aurobindo Pharma Limited)


Welcome to the PulseAid listing for the Atracurium Besylate drug offered from Aurobindo Pharma Limited. This Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Aurobindo Pharma Limited
NON-PROPRIETARY NAME: Atracurium Besylate
SUBSTANCE NAME: ATRACURIUM BESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-04-08
END MARKETING DATE: 0000-00-00


Atracurium Besylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAtracurium Besylate from Aurobindo Pharma Limited
LABELER NAME: Aurobindo Pharma Limited
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/5mL)
START MARKETING DATE: 2015-04-08
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65862-984_5176be07-3121-49fb-9eb9-638903753a31
PRODUCT NDC: 65862-984
APPLICATION NUMBER: ANDA206010

Other ATRACURIUM BESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Aurobindo Pharma LimitedAtracurium Besylate
AuroMedics Pharma LLCAtracurium Besylate
Hospira, Inc.Atracurium Besylate
Mylan Institutional LLCAtracurium Besylate
Sagent PharmaceuticalsAtracurium Besylate